Usporedite metode

	Rimski IV dijagnostički kriteriji za sindrom iritabilnog crijeva	Ljestvica GERD-HRQL za procjenu kvalitete života povezane sa zdravljem	Procjena kvalitete života pacijenata s konstipacijom
Područje	Gastroenterologija	Gastroenterologija	Gastroenterologija
Obitelj	Process / pipeline	Process / pipeline	Process / pipeline
Godina nastanka	2016	1996	2005
Tvorac	Rome Foundation (multinational expert consensus)	Velanovich, V., Zhang, Y., Hollis, J. B., et al.	Marquis, P., De La Loge, C., Dubois, D., et al.
Vrsta	Diagnostic Criteria	Self-report	Self-report
Temeljni izvor	Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation.	Velanovich, V., Zhang, Y., Hollis, J. B., Feldman, M. I., Sampliner, R., Guan, W., & Escamilla, C. (1996). Presenting symptoms and outcome measures in reflux esophagitis. Digestive Diseases and Sciences, 41(10), 1865–1873.	Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005). Development and validation of the Patient Assessment of Constipation-Quality of Life questionnaire. Scandinavian Journal of Gastroenterology, 40(5), 540–551.
Drugi nazivi	Rome IV IBS, Rome Criteria	GERD-HRQL, GERD-HRQoL	PAC-QoL, PAC-Q
Srodne	4	4	4
Sažetak	The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.	The GERD Health-Related Quality of Life Scale (GERD-HRQL) is a concise, validated patient-reported outcome measure for assessing the symptomatic and functional impact of gastroesophageal reflux disease (GERD). Developed by Velanovich and colleagues in 1996, the 9-item GERD-HRQL measures heartburn frequency and severity, regurgitation, and impact on sleep and medication use. The scale is highly responsive to proton pump inhibitor (PPI) therapy and is widely used in GERD trials and clinical practice.	The Patient Assessment of Constipation Quality of Life (PAC-QoL) is a validated, patient-reported outcome measure designed to assess the impact of functional constipation on physical, psychological, and social well-being. Developed by Marquis and colleagues in 2005, the PAC-QoL comprises 28 items organized into four domains: Physical Discomfort, Psychosocial Discomfort, Worries and Concerns, and Satisfaction. The PAC-QoL is responsive to treatment and widely used in constipation clinical trials and practice.